Cancer Research
Results of TNX-355 combination study published in Antimicrobial Agents and Chemotherapy
Published in AIDS Weekly, June 26th, 2006
Synergistic antiviral activity between the two agents was demonstrated against both laboratory and clinical strains of HIV-1 using conventional in vitro techniques. The research demonstrates TNX-355's ability to act synergistically with another drug targeting an early step in the entry cascade and supports the strategy of combining therapies directed at sequential steps of the viral-entry process. Agents are defined as synergistic when the activity seen in combination is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-06-26)
More Articles from AIDS Weekly
- AIDS-Associated Kaposi Sarcoma
AIDS-associated KS prognostic index predicts mortality at initial diagnosis - HIV/AIDS Epidemiology
HIV infection responsible for 49% of disease burden in Zimbabwe - HIV/AIDS Healthcare
Community-based HIV treatment service maintains efficacy after rapid scale-up - KSHV Vertical Transmission
Kaposi sarcoma-associated herpesvirus strains concordant between mother and child - Angiosarcoma & Kaposi Sarcoma
Angiosarcoma can be difficult to differentiate histologically from Kaposi sarcoma - Antimicrobial Resistance
Bacteria tested for susceptibility against piperazinyl-cross-linked fluoroquinolone dimers - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
